VIDEO: Securing the Drug Supply Chain

February 15th 2025

Pharmacists as the Authority on Ultra-High-Cost Drugs

Currently, blood-thinning medications are only prescribed to patients who have already had a heart attack or stroke, as the drugs can cause serious bleeding.

Brian Nowosielski;Erin R. Fox, PharmD, MHA, BCPS, FASHP

Neuroactive Steroid Levels May Indicate Risk of Postpartum Depression

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

American Pharmacies: Powering the Profession Through Leadership

Identifying women who are at risk for postpartum depression sooner can lead to quicker and possibly preventative treatment.

Brian Nowosielski

December 3rd 2024

E. Coli Vaccine Candidate Fails to Demonstrate Efficacy in Phase 3 Trial

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

The investigational vaccine was a 9-valent candidate in development for the immunization against IED in adults aged 60 years and older. | Image Credit: Ezume Images | stock.adobe.com

Focus on What Matters: Sustaining Your Pharmacy in 2025

Investigators note there were no safety signals related to the vaccine candidate, and participants who developed E. coli disease received treatment and care.

Kris Rhea

New Test Could Help Identify Patients That Would Benefit From Blood Thinners

What are some key strategies for keeping your pharmacy thriving in 2025?

Related Content

February 15th 2025

Pharmacists as the Authority on Ultra-High-Cost Drugs

Currently, blood-thinning medications are only prescribed to patients who have already had a heart attack or stroke, as the drugs can cause serious bleeding.

Brian Nowosielski;Erin R. Fox, PharmD, MHA, BCPS, FASHP

Neuroactive Steroid Levels May Indicate Risk of Postpartum Depression

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

American Pharmacies: Powering the Profession Through Leadership

Identifying women who are at risk for postpartum depression sooner can lead to quicker and possibly preventative treatment.

Brian Nowosielski

December 3rd 2024

E. Coli Vaccine Candidate Fails to Demonstrate Efficacy in Phase 3 Trial

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

Focus on What Matters: Sustaining Your Pharmacy in 2025

Investigators note there were no safety signals related to the vaccine candidate, and participants who developed E. coli disease received treatment and care.

Kris Rhea